FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 1873049 · Received October 14, 2010

Report

Report Number
2953161-2010-00187
Event Type
Injury
Date Received
October 14, 2010
Date of Event
September 28, 2010
Report Date
October 13, 2010
Manufacturer
W. L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

METHOD: A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. RESULTS: THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. CONCLUSIONS: ACCORDING TO THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE, THE GORE EXCLUDER AAA ENDOPROSTHESIS AORTIC EXTENDER COMPONENT PROVIDES AN EXTENSION OF THE LEADING END OF THE TRUNK-IPSILATERAL LEG COMPONENT WHEN ADD'L LENGTH AND / OR SEALING FOR ANEURISMAL EXCLUSION IS DESIRED.

Description of Event or Problem · 1

ON (B)(6), 2005, THE PATIENT WAS IMPLANTED WITH THREE GORE EXCLUDER AAA ENDOPROSTHESES TO REPAIR AN ABDOMINAL AORTIC ANEURYSM, AND ONE AORTIC EXTENDER COMPONENT TO REPAIR A DISTAL COMMON ILIAC ANEURYSM. ON (B)(6), 2010, THE PT UNDERWENT A F/U COMPUTED TOMOGRAPHY WHERE A SPACE BETWEEN THE AORTIC EXTENDER COMPONENT AND A CONTRALATERAL LEG COMPONENT WAS NOTED. THERE WAS NO ENDOLEAK OR ANEURYSM GROWTH. ON (B)(6), 2010, THE PT UNDERWENT A REINTERVENTION WHERE A CONTRALATERAL LEG COMPONENT WAS IMPLANTED, BRIDGING THE ORIGINALLY IMPLANTED CONTRALATERAL LEG COMPONENT AND THE AORTIC EXTENDER COMPONENT. THE PT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES WLG325 03782648

Patients

Seq Age Sex Outcome Treatment
1 81 YR Hospitalization| R HYDROCODONE| METOPROLOL| OMEPRAZOLE| PREDNISONE| THE PT'S MEDICATIONS INCLUDE: POLY IRON| GLUCOSAMINE